Study of Re-operation Rate After Introduction of Evidence Based Algorithm for the Treatment of Ankle Fractures (PRO-Malleol)

April 5, 2017 updated by: Peter Toft Tengberg, Hvidovre University Hospital

The PRO-malleol Study

There is a high incidence of re-operations after surgery for ankle fractures. According to the Danish Fracture Database (DFDB) the re-operation rate, excluding hardware removal, is almost 10%.

We are conducting a study on the efficacy of an evidence based algorithm for the treatment of ankle fractures.

Study Overview

Detailed Description

Treatment of ankle fractures is complex and includes assessment of fracture pattern, severity of soft-tissue involvement and general health- and functional status of the patients. Historically most fractures, undisplaced as well as displaced, were treated non-operatively with acceptable results but in recent years there is an increasing trend towards operative management of unstable fractures. Techniques for operative management of ankle fractures are varied and assessment of instability is mainly based on classic x-ray classification systems such as Lauge-Hansen or the AO that are difficult to reproduce[6].

We hypothesize that a standardized and evidence based approach to ankle fracture management will lead to a decrease in re-operation rate.

The aim of this study is to standardize the management of ankle fractures in our department, by introducing an algorithm based on best evidence present. We want to investigate:

  1. The effect of this algorithm on the re-operation rate of surgically treated ankle fractures in a two-year prospective observational setup with a minimum of one-year of follow-up.
  2. The need for surgery and functional outcome of patients with isolated lateral malleolus fractures in which the treatment is dictated by ankle stability assessed on weight bearing radiographs.

Study Type

Interventional

Enrollment (Anticipated)

200

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • All patients treated for ankle fractures at our institution during the study period are asked to participate in the study.

Exclusion Criteria:

  • Not speaking danish Not followed up at our institution Not mentally capable of filling out questionnaire

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Non-Randomized
  • Interventional Model: Sequential Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Prospective Cohort
The prospective cohort following introduction of the evidence based algorithm for ankle fractures.
An evidence based algorithm for ankle fractures
No Intervention: Historical Cohort
Patients treated before introduction of algorithm. Matched to prospective cohort for comparison

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in re-operation rate
Time Frame: one year
Change in re-operation rate following introduction of PRO malleol algorithm
one year
Rate of surgery for isolated lateral ankle fractures
Time Frame: one year
Rate of surgery for isolated lateral ankle fractures, following introduction of algorithm
one year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
SF 36
Time Frame: day 0 and 12 months
SF 36 before fracture and at 12 months
day 0 and 12 months
Ollerud Molander Ankle Score
Time Frame: Before fracture, 6 weeks, 12 weeks and 1 year
Before fracture, 6 weeks, 12 weeks and 1 year
Forgotten Joint Score
Time Frame: Before fracture, 6 weeks, 12 weeks and 1 year
Before fracture, 6 weeks, 12 weeks and 1 year
Before fracture, 6 weeks, 12 weeks and 1 year
Rate of complications not requiring surgery
Time Frame: One year
DVT, Nerve damage,
One year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2016

Primary Completion (Anticipated)

June 1, 2018

Study Completion (Anticipated)

June 1, 2019

Study Registration Dates

First Submitted

April 5, 2017

First Submitted That Met QC Criteria

April 5, 2017

First Posted (Actual)

April 11, 2017

Study Record Updates

Last Update Posted (Actual)

April 11, 2017

Last Update Submitted That Met QC Criteria

April 5, 2017

Last Verified

April 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • PRO-Malleol study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Data will be anonymized and openly shared with any who requests it, after study publication.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Surgery

Clinical Trials on PRO-malleol algorithm

Subscribe